We have used complementatiod analysis after somatic cell fusion' to investigate the genetic relationships among various genetic diseases in humans in which there is a simultaneous impairment of several peroxisomal functions. The activity of acyl-coeizyme A:dihydroxyacetonephosphate acyltransferase,
Introduction
Peroxisomes are organelles bounded by a single membrane and are characterized by the presence of catalase and at least one H202-producing oxidase. They occur in virtually all eukaryotic cells. During the last decade, the importance of peroxisomes in the metabolism of mammalian cells has become increasingly evident. The functions assigned to peroxisomes now include the /3-oxidation of very-long-chain fatty acids (1) (2) (3) , the biosynthesis ofether phospholipids (4) and bile acids (5, 6) , the oxidation of prostaglandins (7) and, in humans, the catabolism of glyoxylate (8, 9) .
In 1973 Goldfischer et al. (10) discovered that morphologically distinguishable peroxisomes are absent in liver and kidney of patients with the cerebrohepatorenal (Zellweger) syn-drome (ZS).' Since that time several genetic disorders have been recognized in which peroxisomal functions are impaired (for review, see references 1 1-13). In some of the disorders a single peroxisomal enzyme is deficient, whereas in others more than one peroxisomal function is impaired.
In one category of diseases with multiple deficiencies there is an impairment of some, but not all, peroxisomal functions.
So far, the only disease described in this category is the rhizomelic form ofchondrodysplasia punctata (RCDP) (14, 15) , the biochemical characteristics of which can be summarized as follows. First, the enzymes acyl-coenzyme A (CoA):dihydroxyacetonephosphate acyltransferase (DHAP-AT) and alkyldihydroxyacetonephosphate synthase are deficient, so that the biosynthesis of plasmalogens is impaired (14, 15) . Secondly, it can be inferred that there is a deficiency of phytanic acid oxidase since there is an accumulation of phytanic acid in body fluids (15 (16, 17) . However, peroxisomes are present, as indicated by the fact that the catalase activity in fibroblasts is particle-bound (15) . In this disease, there is no abnormality in the peroxisomal oxidation of fatty acids (R. J. A. Wanders, unpublished observations).
The second category ofdiseases with multiple dysfunctions comprises disorders with a generalized deficiency of peroxisomal enzymes and a virtually complete absence of morphologically distinguishable peroxisomes. The cerebrohepatorenal (Zellweger) syndrome (ZS), the infantile form of Refsum disease (IRD), the neonatal form of adrenoleukodystrophy (NALD), and hyperpipecolic acidemia (HPA) fall within this category. The biochemical features of these diseases are summarized in Table 5 of Schutgens et al. (13) .
We have used complementation analysis after somatic cell fusion of cultured skin fibroblasts to determine the genetic relationships among the diseases with a partial or generalized impairment of peroxisomal functions. The results described in this article, some of which have been communicated in a preliminary form (18) (19) (20) , indicate that the cell lines studied can be divided into five complementation groups, so that at least five genes must be involved in the assembly of a functional peroxisome.
In an independent study, Roscher et al. (21) Fusion procedure. Cells to be fused were cocultivated for 1 d before the actual fusion in a 1:1 mixture of Ham's F-10 and DME supplemented with 10% (vol/vol) fetal calf serum in 25-cm2 culture flasks (Falcon Labware, Oxnard, CA) under 5% C02/95% air. The amount of cells of each fusion partner was chosen such that confluency was reached within 24 h and the cultures contained an equal number of cells of each cell line. The subsequent steps of the fusion procedure were carried out in the absence of fetal calf serum. A monolayer of the mixture of fibroblasts was washed three times with Ham's F10/DME (1:1). Fusion was carried out by the addition to the monolayer of 0.6 ml of a solution consisting of 41% (vol/vol) PEG and 8.75% (vol/vol) DMSO in Ham's F10/DME (1:1) followed 2 min later by 0.6 ml 25% PEG in Ham's F10/DME (1: 1). The PEG suspension was diluted twice at 2-min intervals with 4 ml of Ham's F10/DME (1:1). The resulting suspension was subsequently aspirated and the fused cells were washed once with Ham's F10/DME (1: 1) before further culture of the hybrids in Ham's F10/DME (1:1) supplemented with 10% (vol/vol) fetal calf serum under 5% C02/95% air. The fusion efficiency (percentage of total nuclei in fused cell cultures present in multinucleate cells) was always in the range of 60-90%.
Assessment ofcomplementation. The occurrence of complementation was tested in three ways. First, acyl-CoA:DHAP-AT activity was measured at intervals 24-120 h after fusion according to (29). Secondly, the percentage of particle-bound catalase was determined at intervals 24-96 h after fusion according to (30) . Thirdly, the presence ofsedimentable catalase was investigated 48 h after fusion by means of Percoll density gradient fractionation essentially according to Oude Elferink et al. (31) . In the gradient fractions the following marker enzymes were assayed: fl-hexosaminidase (lysosomes) (31) was assayed with the corresponding 4-methylumbelliferyl substrate; lactate dehydrogenase (cytosol) was assayed in a medium (final volume 2 ml; final pH 7.4) containing 50 mM potassium phosphate, enzyme preparation, 0.2 mM NADH, and 1 mM pyruvate; catalase activity was measured polarographically in a medium (final volume 280 gl; final pH 7.4) containing 50 mM potassium phosphate, 0.1% (vol/vol) Triton X-100, enzyme preparation, and 10 mM sodium perborate. Protein was determined according to Lowry et al. (32) .
Results

Measurements ofacyl-CoA:DHAP-AT
The activity of acyl-CoA:DHAP-AT in control fibroblasts ranged from 7.7 to 11.9 nmol/2 h * mg protein. In the mutant cell lines the activity was between 0.1 and 2 nmol/2 h * mg protein.
The results of representative fusion experiments involving cell lines from patients with ZS, NALD, RCDP, IRD, and HPA are shown in Figs. 1 and 2 . In the combinations shown in Fig. 1 there was a gradual two-to threefold increase in DHAP-AT activity after fusion. In the cocultivation controls little, if any, increase was observed. These cell lines clearly complement each other. In contrast, there was no significant increase in DHAP-AT activity in fusion experiments involving the cell lines ZS 1, IRD, and HPA, as shown in Fig. 2 . In self fusion control experiments no significant increase in DHAP-AT activity was found; representative experiments are shown in Fig. 3 .
The results of the fusion experiments are summarized in Table I . Thus the cell lines fall into at least five complementation groups (Table II) .
Subcellular localization ofcatalase after complementation Digitonin titration studies. Recently it has been shown that the intracellular localization of catalase in fibroblasts can be established by measuring the latency of the enzyme after a titration of the cells with digitonin (30) . The method is based upon the fact that digitonin forms stoichiometric complexes with cholesterol, that this leads to permeabilization of membranes, and that the various cellular membranes differ in cholesterol content. We used this method to investigate the subcellular localization of catalase after fusion of cells from ZS, IRD, NALD, and HPA patients; these diseases are characterized by a deficiency of functional peroxisomes (see for reviews references 1 1-13) and particle-bound catalase is absent. However, the enzyme is not deficient, but is localized in the cytosol (30, 33, 34) .
The results of a typical digitonin titration experiment involving ZS2 and IRD cells are shown in Fig. 4 . Only a small amount of digitonin (< 40 ,ug/ml) was needed to release all latent catalase enzyme activity in cocultivated ZS2 and IRD cells. This indicates that in ZS and IRD fibroblasts catalase is not localized in peroxisomes (30, 34) . Fused ZS2 and IRD cells showed a different behavior. In the heterokaryons much higher concentrations of digitonin (> 200 gg/ml) were required to abolish catalase latency completely. These concentrations were in the range of those necessary to release latency of peroxisomal catalase in control fibroblasts (26) . Thus, the results indicate that in ZS2 X IRD hybrid cells catalase-positive particles (presumably peroxisomes) were formed. Comparable results were obtained using other combinations of ZS, IRD, NALD, and HPA fibroblasts that showed complementation with regard to DHAP-AT (results not shown).
Percoll density gradient centrifugation studies. Another means of studying the subcellular localization of catalase is to use Percoll density gradient fractionation. Fig. 5 showed complementation with regard to DHAP-AT (results not shown).
Taken together, the results of the catalase latency and sedimentability studies show that after complementation particles arise that are able to incorporate catalase. These particles behave like normal peroxisomes in latency and sedimentability studies.
Discussion
Our complementation studies clearly show that at least five genes are involved in the biogenesis of a functional peroxisome. Gene 1 (complementation group 1) encodes a protein necessary for the expression of DHAP-AT, alkyl DHAP synthase, and phytanic acid oxidase; this protein could represent a receptor necessary for incorporation of the enzymes into a peroxisome. Genes 2, 3, 4, and 5 (complementation groups 2, 3, 4 and 5) code for proteins necessary for the assembly of functional peroxisomes; the proteins could be either membrane components and/or cytosolic factors. Since Roscher et al. (21) have identified two complementation groups within cell lines from patients with NALD, an additional gene may be involved in the assembly of peroxisomes. It has been suggested earlier by Goldfischer and Reddy (12) that there may be different subgroups of ZS. The results reported in this article provide objective evidence that this is, indeed, the case. However, it should be noted that the cell lines in group 2 were obtained from patients diagnosed clinically as having different disorders. Thus cell line GM 3605, which was obtained from a cell bank, was derived from a patient described as having HPA (27) . According to our data HPA, in this patient at least, is not a separate disease but is one of the subgroups of ZS.
At least three possible reasons for the absence of complementation between the cell lines in group 2 can be considered. First, the disorders might be caused by allelic mutations. Secondly, they may represent phenotypic variations of the same GOM85AD) and IRD fibroblasts. The fibroblasts were fused using PEG as described in Methods. At various days after fusion or cocultivation, the percentage of particle-bound catalase was determined by means of digitonin titration.
mutation. Thirdly, the absence of complementation after fusion oftwo cell lines might be due to the absence ofpreexisting peroxisomes, since it is now generally accepted (35, 36) Figure 5 . Distribution of marker enzymes after Percoll density gradient fractionation of control fibroblasts, two complementary Zellweger cell lines, and heterokaryons formed by fusion of the two mutant cell lines. The mutant cell lines used were W78/515 (ZS I) and GOM85AD (ZS2); the cells were fused using PEG as described in isomal functions, even within the clinically relatively homogeneous ZS. A similar conclusion has been reached by Roscher et al. (21) . With regard to the observed genetic heterogeneity within ZS, it is of interest to consider the medical background of the patients under study. Interestingly, the ZSl cell lines (complementation group 2) were all derived from patients ranging in age from 2 to 6 yr. In contrast, the other ZS cell lines, ZS2 and ZS3 (complementation groups 3 and 5) were obtained from patients who died at the age of 3 and 5 months, respectively. Thus, it is clear that mutations in two different genes can lead to the same clinical and biochemical phenotype.
Further studies are needed to assess the function of the various gene products necessary for the assembly of a normal peroxisome. Isolation and characterization ofthe genes and of their products should in the future increase our insight into the molecular background of various hereditary peroxisomal disorders.
